Bette Jacobs - Oct 28, 2022 Form 3 Insider Report for Shuttle Pharmaceuticals Holdings, Inc. (SHPH)

Role: Director
Signature: /s/ Bette Jacobs
Stock symbol: SHPH
Transactions as of: Oct 28, 2022
Transactions value $: $0
Form type: 3
Date filed: 11/9/2022, 09:11 AM
Next filing: Jan 3, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	SHPH	COMMON STOCK						35.6K	Oct 28, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The undersigned became a Reporting Person subject to Section 16 reporting on October 28, 2022, the date on which the Reporting Person commenced service as a director of Shuttle Pharmaceuticals Holdings, Inc. ("Company"). Upon her appointment to the position of director, on October 28, 2022 (the "Grant Date"), the Company awarded the Reporting Person 35,587 Restricted Stock Units ("RSUs"). One-third of the RSUs became vested on the grant date, with the remaining two-thirds subject to vesting in substantially equal installments on the first and second year anniversary of the Grant Date.

Content

The undersigned became a Reporting Person subject to Section 16 reporting on October 28, 2022, the date on which the Reporting Person commenced service as a director of Shuttle Pharmaceuticals Holdings, Inc. ("Company"). Upon her appointment to the position of director, on October 28, 2022 (the "Grant Date"), the Company awarded the Reporting Person 35,587 Restricted Stock Units ("RSUs"). One-third of the RSUs became vested on the grant date, with the remaining two-thirds subject to vesting in substantially equal installments on the first and second year anniversary of the Grant Date.